The Society of Practising Veterinary Surgeons (SPVS) has launched a new Profitability Survey to measure profitability levels across the nation’s veterinary practices and provide a benchmark for practices to assess their performance against.
Launched this month, the SPVS Profitability Survey is available to all practices, both members and non-members. It can be completed online using figures from the practice’s most recent set of accounts and the practice management system. All the data is kept completely confidential for practices to securely access their results online.
Once they have completed the survey, participating practices will be given an overall practice profitability score from excellent, good, average, below average and poor. Practices will also be able to benchmark against Key Performance Indicators such as: the cost of drugs and supplies; the cost of personnel; and cost of overheads.
Peter Brown, SPVS Treasurer and author of the survey said: "We’re particularly pleased to be launching this Profitability Survey. As the saying goes, turnover is vanity and profit is sanity. Profitability is key to any business yet we’re often told that veterinary practices fare badly when it comes to this fundamental point. Knowing how your business is performing and how it compares to others should be a priority for all practice principals and one that our new Profitability Survey will be able to answer.
"We are delighted to be working with John Sheridan on this subject. John has long been a passionate advocate of the need for practices to understand their profitability and he has helped SPVS to develop this simple survey to provide practices with the key statistics they need. Furthermore, the pooled, anonymised data will be used by SPVS to help us tailor CPD and expert advice for members on this critical aspect of their business. The more data we have the more accurate analysis we will be able to provide so we would urge all veterinary practices to complete the survey."
SPVS’ existing Fee and Salaries Surveys have also been enhanced with improvements to the way data is entered and results presented through a dedicated website developed with Veterinary Insights. Published earlier this year, the Salaries Survey revealed that there is a widening pay gap between newly qualified vets whose median salary actually fell by 3.7% and more experienced vets who attained increases of between 2.6% and 10.8%. However, while newly qualified vets compared favourably with their equivalents in the medical and dental profession, those more experienced lag some way behind.
To take part in the new SPVS Profitability Survey visit www.spvs.org.uk
The investment is being made to increase the speed at which concerns are either closed or referred, ensure that the process meets its service standards and reduce stress for the public and profession.
The decision to increase investment in the process was made by the College’s Operational Board in response to a steady increase in the number of concerns being investigated. The College forecasts that it will receive in excess of 1,000 concerns raised about the professional conduct of veterinary surgeons and veterinary nurses this year.
The RCVS developed a simplified, three-stage concerns process in 2014 which included the introduction of targets for cases to be either closed or referred at each stage. In order to ensure that these targets can be met, the College will now be hiring five paralegals to assist the existing five case managers.
Eleanor Ferguson, Acting Registrar, said: "Currently we are only closing or referring just over half of concerns we receive at stage 1 (case examiner stage) within our four month target. In order for the system to run more smoothly we will be investing in extra staff to help clear the backlog and ensure that these targets are met going forward.
"Similarly, in order to deal with the increase in the number of cases being referred to Preliminary Investigation Committee (stage 2), we will be increasing the frequency of these committee meetings from one to two per month.
"It is important to add that this investment is not just about dealing with concerns more quickly but is also about quality of service and having more staff on hand will ensure that this quality is maintained in terms of how we communicate with complainants and members of the profession. Speeding up the process will reduce the stress and anxiety felt by all involved."
More details about the College’s concerns investigation process and its different stages can be found at www.rcvs.org.uk/concerns
Mr Bowles faced four charges, but did not respond to the College's notification about the hearing, so the Committee decided to proceed in his absence.
The first charge was that in 2020, while attending a farm in Lincolnshire in his capacity as an Official Veterinarian (OV), Mr Bowles carried out Intradermal Comparative Tuberculin (ICT) tests on a herd of cattle but failed to measure the skin thickness of all the cattle using callipers and failed to take and record measurements for the cattle.
The Committee was provided with evidence that Mr Bowles had, in earlier correspondence with the College, admitted that he had failed to follow Animal and Plant Health Agency (APHA) standard operating procedures for ICT testing at the farm and so the charge was found proven.
The second charge was that he then certified the results of the inaccurate ICT test he'd performed earlier.
The Committee found this charge proven on the basis that, without using callipers to measure skin thickness, he was not entitled to certify the test.
The third charge was that his conduct in relation to the first two charges was dishonest, misleading and risked undermining government testing procedures designed to promote public health and animal welfare.
The Committee found all elements of the charges proven.
The final charge was that Mr Bowles's conduct took place despite warnings, advice and re-training being given by the APHA.
These included: a letter sent to Mr Bowles’s by APHA in 2014 about the suspension of his OV status after he failed to comply with APHA rules; a letter sent by the APHA to Mr Bowles’s employer in October 2016 regarding issues of non-compliance it had found during a September 2016 audit; and the suspension of Mr Bowles’s OV duties by his employer, pending further training, following issues of non-compliance.
Given Mr Bowles’s history of non-compliance with APHA standard operating procedures and standards, the Committee found the charge proven.
The Committee found that charges 1 to 3 amounted to serious professional misconduct but that charge 4, while making the conduct in the other charges more serious, did not in and of itself constitute serious professional misconduct.
In determining the most appropriate sanction for Mr Bowles, the Committee found that he had paid ‘scant regard’ to the testing procedures set out by APHA and breached the RCVS certification requirements set out in the Code of Professional Conduct for Veterinary Surgeons in ‘numerous and serious’ ways.
Hilary Lloyd, chairing the Committee and speaking on its behalf, said: “The Committee’s view is that the respondent’s conduct in refusing to follow the OV Instructions when testing cattle in May 2020 constituted conduct of an egregious kind.
"In addition, there are several aggravating elements which can be applied to his misconduct, including a risk to animal or human health; his lack of probity and integrity in certifying test results which he knew were non-compliant and unreliable; recklessness in reaching a conscious decision to ignore the OV Instructions; his failure to comply with the requirements of the position of trust and responsibility which attached to his APHA authorisation; and against a backdrop of sustained pattern of behaviour that displayed blatant disregard of the system that regulated TB testing by OVs.
"It follows that the respondent manifested no insight into the seriousness of his misconduct when acting as an OV.”
The Committee considered whether there were any mitigating factors regarding Mr Bowles’ conduct.
It took into account that Mr Bowles had not secured any financial advantage, that there was no actual harm to animals, and that he had a long career as a veterinary surgeon, although with a history of non-compliance.
It noted that there had been some late admissions of misconduct by Mr Bowles when he tendered an apology, but found this mitigation was undermined by the fact his explanations lacked consistency and that he had also initially asserted that he had used callipers during the testing.
Due to the seriousness of the non-compliance, the dishonesty and the potential risk to public health, the Committee considered that removing Mr Bowles from the Register was the only proportionate and appropriate response to the scale of misconduct.
Hilary added: “Given the amount of advice received and re-training which the respondent was required to undertake, he has already had ample opportunity to remediate his practice but has not done so.
"The Committee is therefore concerned that there is a very real risk of further repetition of this conduct in the future were he to be permitted to remain on the Register.
“The Committee’s concern in this regard stems from the fact that the dishonesty of which the respondent has been found guilty, was not dishonesty committed on the spur of the moment.
"The respondent had ample opportunities for reflection before resolving to act as he did.
"This places his acts of dishonesty in the most serious category.
“The public is entitled to expect that it can have confidence in the certifications of a veterinary surgeon who is carrying out a public duty on behalf of that public body.
"Indeed, that is the whole purpose behind the requirement that OVs undertake additional and specialised training before being permitted to undertake OV duties.”
www.rcvs.org.uk/disciplinary
The RCVS Disciplinary Committee has dismissed a case against a Nottinghamshire veterinary surgeon, having found not proven the charge that he had caused, allowed or failed to prevent a potential breach of the Rules of Racing of the Greyhound Board of Great Britain (GBGB).
During the re-scheduled, three-day hearing, the Committee heard that Dr Gary Samuel was on duty on 10 October 2009 as the GBGB licensed track veterinary surgeon at Nottingham Greyhound Stadium. When the trainer came to collect her dog for the race, she discovered a biscuit in his kennel in the paddock area, in potential contravention of the rules of the GBGB, which do not allow greyhounds access to any food, drink or other substance after weighing in, prior to a race. She reported this discovery to the paddock steward. The dog was withdrawn from the race, so there was no prospect of prize money. The trainer, despite her unblemished record, was put at risk of disciplinary action by the GBGB, which could have resulted in the loss of her training licence and livelihood. Following the events of 10 October, the GBGB held a disciplinary hearing, at which Dr Samuel was disqualified indefinitely from holding a GBGB licence and fined £2,500, and the matter was referred to the College.
The RCVS Disciplinary Committee confirmed that it should not be bound by the GBGB decision, and that the charges laid against Dr Samuel must be resolved on the basis of the evidence before it. Both Counsel for Dr Samuel and the College urged the Committee to have close regard of CCTV footage from 10 October, which showed Kennel 21 where the dog had been placed and the biscuit found. From evidence given by the paddock steward and the trainer, the Committee accepted that the kennel was clean when the dog entered at 5.30pm, so the biscuit must have been introduced between 5.30pm and 9pm, when the trainer collected him for the race.
The footage available to the Committee from Nottingham Race Track was only four-and-a-half minutes long. The Committee was concerned that there were almost three-and-a-half hours of footage that it had not been shown and that, in addition, witnesses were not able to state that they had viewed the remainder of the footage. In those circumstances, the Committee considered that the footage available must be of the best quality to allow it to reach a sure conclusion as to what exactly Dr Samuel may have been doing in his position close to Kennel 21. From the quality of the footage available, the Committee was not able to be sure.
Speaking on behalf of the Disciplinary Committee, Vice-Chairman Professor Sheila Crispin said: "The fact remains that the Committee cannot be sure that the Respondent caused the biscuit to enter Kennel 21, [so] finds the charge against the Respondent not proved."
Dr Samuel therefore remains on the RCVS Register and is entitled to practise.
The campaign was created to highlight individual perspectives on what animal health looks like, with contributions from veterinary surgeons, politicians, NOAH members, animal charities, industry experts, livestock stakeholders and pet owners.
Contributions have included images of ‘cleaner fish’ and their role as a safe, effective and sustainable form of biological control for salmon, medical detection dogs, assistance animals who improve the quality of life for their owners, and household pets and livestock that play a key role in our lives.
VetSurgeon.org's favourite so far is the photograph by BVA Vice President Gudrun Ravetz (shown right). She said: "It was a rare moment of peace in the house and showed why one health is important. The two of them are one inseparable unit of fun and trouble, but their health is interlinked. The parasite control that I use with Tess is informed by her contact with Leo and the environment she runs in and the lessons Leo learns about dog behaviour and animal welfare will inform and protect him. They exercise each and are good for each other’s mental health.”
Dawn Howard, NOAH chief executive, says:"We’re delighted to see that so many people are keen to show what animal health means to them. With such breadth of images, it’s fascinating to see so many different perspectives and we look forward to many more.
"Animal health means something very different to each and every one of us. The images showcased through the contributions highlight what a varied and inspiring industry we work in and the passion of the people involved in it.
"The campaign is all about keeping animal health at the forefront of everyone’s minds, not only to celebrate the work that we, as an industry, do to keep animals happy and healthy, but also to address challenges that have the potential to put our animals’ health at risk, and ensure that the UK continues to lead the way for good animal health and welfare."
The first event, being held tomorrow (19th May) at 11:00pm, will be presented live from Calgary by small animal ECC specialist, Dr. Marie Holowaychuk.
Marie has spent more than 15 years speaking to audiences around the world, drawing on her personal experiences and evidence-based information to empower veterinary professionals to look after their personal and professional wellbeing.
Next week, at 8pm on Thursday 26th May, Andy Green MRCVS (pictured right), people director at Kent-based Pennard Vets, will host the second event titled ‘From Victim to Victor.’
His presentation will explore the challenges of clinical life and provide insight into how building healthy habits form the foundations for long-term success in the veterinary industry.
Andy is a certified neuro strategist who has spent the last 15 years exploring the world of personal development.
He's also a regular speaker at vet schools, conferences and events.
Lance Rice, creative director at ezyVet, said: “We’re already on target to have more than 1,000 vets and nurses from practices across the world attending these free webinars that are hosted by veterinary professionals for veterinary professionals.
“Because our hosts and audience are spread across the world, we know that some people won’t be able to watch them live, so we’ll make them available to view again afterwards through our website.
"Both promise to be invaluable events that will also count towards annual CPD requirements, so we’re encouraging vets and nurses to sign up now.”
You can register at: www.ezyvet.com/mindfulmay
Sanofi-aventis and Merck & Co., Inc. announced today that Sanofi-aventis has exercised its option to combine Merial with Intervet/Schering-Plough, Merck's Animal Health business.
The new joint venture will be equally-owned by Merck and Sanofi-aventis. The formation of this new joint venture is subject to execution of final agreements, antitrust review in the United States, Europe and other countries, and other customary closing conditions. The completion of the transaction is expected to occur in approximately the next 12 months.
Richard T. Clark, Merck Chairman, President and Chief Executive Officer said: "Merck has been in the animal health business for well over six decades and through this new joint venture, we will bolster our diverse portfolio and create a new global competitor poised for growth.
"This new joint venture delivers on Merck's commitment to customer focus by creating one of the broadest portfolios of animal health products and services in pharmaceuticals and biologics for millions of customers who include farmers, veterinarians and pet owners. The planned joint venture will have an attractive geographical network of global technology and expertise to provide health solutions based on customers' needs, which often vary regionally."
The worldwide animal health market reached $19 billion in 2008. Products for companion animals accounted for 40 percent of total sales while products for production animals accounted for the remaining 60 percent of total sales. This market is expected to grow at around 5 percent per year over the next 5 years, driven by a growing demand for animal proteins, as well as a strong consumer needs for companion animal health care.
The companies said that both Merial and Intervet/Schering-Plough will continue to operate independently until the closing of the transaction.
Dechra Veterinary Products is offering CPD sessions as podcasts for the first time, as part of a new series of presentations on canine hyperadrenocorticism.
The Cushing's Challenge series, which will also be available as webcasts with supporting notes, is designed to challenge vets to update their knowledge on the syndrome.
There will be six presentations released on the company's online learning resource, The Dechra Academy, starting this month.
Dechra Veterinary Products Brand Manager, Craig Sankey said: "Although Cushing's is a common canine endocrinopathy, it can be challenging to diagnose and can mimic non-adrenal disorders. Test results can also sometimes be inconclusive which is why we've developed this series of CPD sessions to support veterinary professionals who want to update their knowledge.
"The Cushing's Challenge series will be the first time Dechra has used podcasts to deliver CPD, which can be downloaded and listened to on any MP3 player. They can also be viewed on a PC or tablet as a webcast with each of the presentations varying in length, from around 12 to 25 minutes long. By offering the presentations in both of these formats, we are able to offer flexible support to help busy veterinary professionals with CPD.
"The first episodes will focus on pathophysiology, clinical signs and routine lab tests with successive presentations released in the coming weeks. The next two in the series will cover diagnostic tests and then differentiation tests."
CPD certificates will be available at the end of the series via email.
The free-of-charge CPD is accompanied by client support materials for practices as part of Dechra's new Vetoryl campaign.
The Cushing's Challenge CPD is available at www.dechra.co.uk/academy,
The WSAVA is calling on veterinary surgeons around the world and anyone with an interest in veterinary – and human – medicine to sign the petition to ensure access to ketamine in the face of lobbying by some countries, principally China, to have it put under international scheduling.
According to the WSAVA, proposals for international control stem from the misconception that ketamine is merely a 'recreational drug.' The WSAVA says this is inaccurate and devalues its huge contribution to human and animal medicine.
Dr Walt Ingwersen, WSAVA President Elect and Member of the WSAVA’s Global Pain Council, said: "In 2015, the WHO Expert Committee on Drug Dependence (ECDD) stated that the abuse of ketamine does not cause a global public health threat and that control would limit access for those using it as an anaesthetic. This view was confirmed at a meeting of the UN Commission on Narcotic Drugs in March 2016, helped by strong support view from the global medical and veterinary communities. However, China has repeated its view that ketamine should fall under international scheduling and we have no doubt that it will raise the issue again. This mean the risk to ketamine remains."
He added: "Ketamine is a safe anaesthetic which can be used without oxygen, ventilators, electricity and the support systems required for other products, making it the only anaesthetic suitable for both medical and veterinary use in lower and middle income countries. If developing countries were denied access to it, which would be the effect of international scheduling, the effects on veterinary medicine, human health and animal welfare would be devastating."
Dr Ganga de Silva, President of the Society of Companion Animal Practitioners of Sri Lanka, said: "Sri Lanka is a poor country with an underdeveloped veterinary profession. If ketamine was not available, in my opinion, all surgeries would have to cease as almost all of the veterinarians in the country rely on it for anaesthesia. The result would be suffering for animals and it would also seriously impact our ability to control rabies as we would not be able to carry out spay and neuter programs on stray dogs."
Dr Nancy Shaffran CVT, VTS(ECC), President of the International Veterinary Academy of Pain Management, said: “In addition to its use as an anaesthetic agent, ketamine is a critical medication used in the pain management in animals. The mechanism of action of ketamine (NMDA receptor antagonism) delivered as a Constant Rate Infusion has been well established to be effective in the prevention and correction of severe neuropathic pain and spinal cord wind-up. The loss of ketamine in veterinary practice would result in the needless suffering of many patients and we strongly oppose this action. We are very grateful for WSAVA’s efforts to keep ketamine available for our patients."
Dr Walt Ingwersen added: "Ketamine is also used in human medicine as it has a particular value for use 'in the field' - for instance, in treating trauma patients, those with traffic and sporting injuries or affected by natural disasters and conflict. Taking these factors together, it is clear that ketamine is an essential medicine and we are determined to ensure that it remains freely available. We are continuing to harness our global veterinary community to highlight the importance of ketamine because this is a battle our patients can’t afford us to lose. We ask all those agreeing with to sign our petition and help our collective voice grow."
The petition is here: http://chn.ge/1RFSou6.
The WSAVA’s Global Pain Council has produced a range of tools and resources, including an infographic, to support its ketamine campaign. They can be accessed here: http://www.wsava.org/educational/global-pain-council
For the study, titled “RHDV2 epidemic in UK pet rabbits. Part 1: clinical features, gross post mortem and histopathological findings”1, veterinary surgeons were encouraged to submit case histories and the results of post mortem examinations of pet rabbits that died suddenly. Samples taken during the post mortem were sent for histopathological examination.
Frances Harcourt-Brown, corresponding author for the paper, said: "Case histories, macroscopic findings and histopathology results were available from 300 rabbits that died suddenly.
"Of these, 185 (62%) died from RHD and showed characteristic histopathological features of RHD including apoptosis and variable lytic and coagulative hepatocellular necrosis, with varying distribution.
"Interestingly, macroscopic evidence of disease was not present in all cases – for example, gross liver abnormalities were only reported in 30% of cases, despite all cases showing hepatocellular necrosis on microscopic examination.
"Rapid death and death of other rabbits in the household were common features of RHD.
"Histopathology was also useful in yielding valuable information about other causes of death in the rabbits that did not die from RHD.”
Nicola Di Girolamo, editor of JSAP said: “This is a terrible disease that is currently spreading in areas of the world that were free from it until recently. Having more evidence on the type of clinical presentations and lesions that should be expected with this disease in rabbit patients is going to be of tremendous value for clinicians. Given that there is not always macroscopic evidence of RHD, histopathology is key for the diagnosis of RHD in pet rabbits.”
The full article can be found in the July issue of the Journal of Small Animal Practice which is free for BSAVA members.
It can also be read online here: https://www.onlinelibrary.wiley.com/doi/full/10.1111/jsap.13141
Reference
Photo: BSAVA
Topics covered will include practical applications of enrichment for zoo species, options for reproductive control in pet ferrets, challenges of exotics out-of-hours care, veterinary care of invertebrates and decision-making in wildlife cases.
The Association says that this year, there will be a greater focus on masterclasses, practical sessions and roundtable discussions, and that there will be plenty of new research, case reports, case series and the most recent advancements in the field of zoo, wildlife and exotic animal medicine.
There will be dedicated streams covering zoo health, nursing, exotic pets and wildlife health, together with a stream for students and new graduates.
The social programme includes the student-mentor mixer, a wine and canapés evening, a gala dinner and silent disco.
Registration fees have been held at the same level as 2019: tickets for non-members range from £410 for one day, to £760 for all three; members get a discount.
www.bvzs.co.uk
Her Royal Highness Princess Anne has opened the Royal Veterinary College's new Teaching and Research Centre.
The Centre - at the college's Hawkshead Campus in Potters Bar, Hertfordshire - will provide a home for the RVC's lifestyle research, which includes conditions such as obesity/diabetes, chronic kidney disease and arthritis as well as those with genetic roots.
RVC Principal Professor Stuart Reid said: "The RVC is extremely proud to have welcomed Her Royal Highness to open the new Teaching and Research Centre - a facility where our students are taught within an environment that is all about advanced scientific discovery and first class research. The building houses the engine of academic enquiry and is a wonderful space where our academic community generates new insights into diseases that affect humans and animals.
"The Centre allows us to tie together the various threads we have around the study of illnesses that result from lifestyle in humans and animals, such as those associated with age or genetic disorders. Our College collaborates with the research hub that is the London scientific research community. We are extremely well placed to carry out the work in conjunction with human medical research groups and bring the veterinary perspective to the understanding of disease. The building offers new opportunities, both nationally and internationally".
Funding for the building of the new centre was provided by HEFCE and The Wolfson Foundation.
Photo: Paul West
A review of past research papers on the treatment of feline diabetes carried out by Dr Stijn Niessen at the RVC has found that much of the research into the condition was based on low-level evidence, lacked a cooperative approach and, therefore, yielded questionable results.
According to Dr Niessen, current recommendations are often based on previous research studies which used small sample sizes; some included as little as 8 cats. The biggest sample sizes found contained from 50 to 60 cats, but Dr Neissen says that even this isn't a big enough sample size to yield effective results. He says that so-called power calculations, a statistical test performed as part of this new publication, indicate that at least 80-90 animals are needed to accurately compare the effectiveness of different insulin types and other treatments.
Stijn said: "The only way to improve the quality of research and its results is to design and implement well-structured clinical trials, similar to those used by pharmaceutical companies in human medicine.
"This sort of trial can have a powerful impact on a treatment and how it is used. They can more accurately gauge the pros and cons of specific diabetic treatments for cats, helping us pinpoint troublesome side effects as well as identifying the benefits.
"Current research into the condition is sporadic, lacking a long-term vision and not collaborative. A pet owner can, in theory, go to two different vets and get two very different treatments for the same condition. The owner could then go online and find a third way. These treatments aren't necessarily wrong, it is just one vet may have been trained in one methodology and another in a different way. This is why a collaborative approach is so important, so we can end these inconsistencies and can get closer to the actual truth about which way best to treat our feline friends."
For more information, visit: https://www.facebook.com/RVC.Diabetic.Remission.Clinic
Hysolv Animal Health UK has announced that it is offering a free diagnostic test which allows vets to identify the E. coli sub-types that produce the Shiga toxin associated with oedema disease in pigs.
The test, known as STEC-Check and worth £150-£200, is being sponsored by IDT Biologika GmbH. In the UK and Republic of Ireland, faeces and/or intestinal samples will be sent to the Animal Health and Plant Agency (APHA), Weybridge and SAC Consulting Veterinary Services at Penicuik to confirm results within a few days.
Hysolv says the test will provide a quick and accurate diagnosis, enabling appropriate action, including vaccination, to be taken on the farm.
Richard Brealey from Hysolv said: "Oedema disease is not always obvious and may be masked or controlled by the use of antibiotics, the use of zinc oxide or low-protein feeds which can also negatively affect productivity. This test will help confirm the presence of Shiga-toxin producing E. coli on the farm, a cause of serious losses in individual herds. We are therefore advising farmers to contact their vets to discuss using STEC-check on their farms."
According to the company, a nationwide study in Germany showed that 59% of farms where oedema was suspected were affected by Shiga toxin.
Richard added: "The Ecoporc Shiga vaccine has been recently licensed for use in the UK. There is pressure on vets and farmers to reduce the use of antimicrobials and vaccination, together with other measures, and this will help them to do this."
In the UK farmers will be able to carry out a DIY calculation of their return on investment online, using their smartphones or by visiting the Shiga toxin website www.shigatoxin.com
Ceredigion veterinary surgeon Robert Alun Merfyn Evans has been suspended from the Register for six months by the RCVS Disciplinary Committee after he admitted to misconduct relating to tuberculin testing for cattle he owned and failing to register the births and deaths of cattle.
Mr Evans appeared before the Committee on the 11th February, when he admitted the two heads of charge of misconduct against him.
The first head of charge related to the fact that, between 24 June and 29 June 2013, he deliberately failed to bring to attention of Wyn Lewis MRCVS, an Official Veterinarian (OV) and fellow director of Mr Evans’ practice in Cardigan, the cattle on his farm requiring intradermal comparative tuberculin tests; that he tested certain of the cattle himself despite not being the OV for those tests and having a conflict of interest; and that he provided inaccurate and incomplete information to his practice for the completion of a report on the testing to be sent to the Animal Health and Veterinary Laboratories Agency (AHVLA). This misconduct was then repeated the following year between 19 June and 1 August 2014.
The second head of charge against Mr Evans related to breaches of the Cattle Identification (Wales) Regulations 2007 between 4 July 2005 and 20 June 2014, namely the fact that he failed to register the birth of five calves and the death of nine cows. These were accepted as being specimen charges reflecting a much larger total number of breaches over the whole nine year period.
Mr Evans’ misconduct first came to light when a late return was sent to the AHVLA in August 2014 regarding the TB testing of 51 live animals on his farm in June 2014. When the report was scrutinised the AHVLA noticed that 26 animals shown on the return as dead were still registered, while 20 animals that were tested were not registered. When the AHVLA investigated, Mr Evans immediately admitted that he had misled Mr Lewis on two occasions and carried out his own testing despite not being the OV.
The Committee heard that he did this because he did not want it to be found out that he had unregistered cattle on his farm. Regarding the unregistered cattle, the Committee heard that this stemmed from a mistake made by Mr Evans in 2005 or 2006 whereby he mislaid a batch of around nine bovine passport application forms sent to him to register the birth of calves on his farm, a legal requirement for the purposes of animal health, disease control and safeguarding the food chain.
As a result of poor IT skills and being profoundly deaf, Mr Evans felt unable to seek support online or by telephone, was too embarrassed to tell others and, furthermore, felt that it was impossible to correct his mistake without being in breach of the law. So, for a period of nine or 10 years, he failed to register the birth of calves on his farm. His failure to register the deaths of cattle, was also caused by administrative failings. His breaches of the cattle registration regulations were subject to criminal proceedings and on 14 October 2015 he plead guilty at Ceredigion and Pembrokeshire Magistrates Court to 14 offences for which he was given a conditional discharge for 18 months and ordered to pay costs of £1,000.
The Committee considered that a suspension from the Register would be in line with the seriousness of the charges against Mr Evans. Professor Alistair Barr, chairing the Committee and speaking on its behalf, said: "The Committee agrees that the lengthy period over which these offences took place, his betrayal of his colleague, and the undermining of the reputation of the profession and of the system of disease control, taken together with his dishonesty, make it impossible to impose a lesser sanction than suspension.
"The Committee finds that the respondent, who is a man of good character, has fully accepted his guilt, and has real insight into the seriousness of his conduct. He cooperated fully with the investigations and with the County Council who prosecuted him in the Magistrates [Court], and with the College. He made an open and frank admission about his misconduct from the outset.
"The course of conduct on which he embarked and which has led to these charges was the result of a simple mistake at a time of considerable stress to him. He was not guilty of deliberate misconduct at the outset but… what started as an innocent mistake took on a life of its own and led him to deliberate and dishonest misconduct because he did not know how to get himself out of the predicament he was in."
Professor Barr also said that there was no financial gain in Mr Evans’ actions and that animal welfare had not been compromised as the cattle were well cared for and in good health and that Mr Evans’ actions in carrying out the tuberculin tests on the unregistered cattle himself demonstrated that he was concerned about identifying any disease in his herd.
He added: “In all the circumstances the Committee has decided a proportionate sanction is that the respondent’s registration should be suspended for a period of six months.”
The Committee’s full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
Two companies have simultaneously announced new services to help veterinary practices put systems in place to keep in regular contact with their clients via email.
The first is the veterinary PR and copywriting consultancy MC Communications, which offers to design, copywrite and distribute emails to your clients as often as you wish to email them. Alternatively, they'll fix you up with an account at Constant Contact, and you can email clients yourself.
The second is from Guthrie Communications Ltd (aka me), publishers of vetsurgeon.org and vetnurse.co.uk. They'll design and build a bespoke website for your practice which is so easy to keep updated, the practice cat could do it. Here's one they prepared earlier: www.putlandsvets.com
Guthrie Comms websites also include a simple system for capturing your website visitors email addresses, which are passed automatically and seamlessly to the Manymail bulk emailing system. We'll also set you up with a template you can use to email clients. Alternatively, MC Communications will copywrite emails for use on this system too.
The difference between the two services? Well, the one offered by MC Communications is going to be better suited to those practices that already have a polished online presence, and are now looking to use e-mail more effectively.
Our service, on the other hand, is for those who want to start using email more effectively but don't yet have a website (or perhaps have one in dire need of a good haircut).
For more information contact Marie at MC Communications on 0191 373 7830, or me (Arlo) on 020 7183 2511.
From 31 October 2008, veterinary surgeons will again be allowed to charge animal owners for writing prescriptions, when a three-year ban on such fees comes to an end.
The Supply of Relevant Veterinary Medicinal Products Order 2005 was introduced by the former Department of Trade and Industry (DTI) to implement recommendations from a 2003 Competition Commission inquiry into the supply of prescription-only veterinary medicines, which, among other things, found that prescription charges were against the public interest. It was hoped by the DTI that the move would benefit consumers by providing for pharmacies and other suppliers to have an opportunity to establish themselves as competitors to veterinary surgeons in supplying prescription-only veterinary medicines.
Although veterinary practices will be able to make a charge for writing a prescription from 31 October 2008, one thing does not change: practices must not charge different fees for other services or veterinary medicines to those who take a prescription and those who do not.
Jill Nute, RCVS President said: "The OFT (Office of Fair Trading) will monitor the reintroduction of prescription charges and has indicated that the level of monitoring will be proportionate to the perceived need - how well the market is working.
In addition, the RCVS will monitor complaints that relate to prescription charges and meet with the OFT to review the situation in six months time. Care must be taken to ensure that prescription fees are calculated sensibly, or the zero-fee ruling may be reintroduced."
The OFT has advised that veterinary practices must not agree between themselves what constitutes a suitable fee: it is prohibited by competition law.
General guidance for members of the profession is available on RCVSonline (Advice Note 15): www.rcvs.org.uk/advicenotes. Guidance for members of the public is also available online at:
http://www.consumerdirect.gov.uk/before_you_buy/thinking_about/560042/
Other Competition Commission recommendations, such as displaying a price-list of the ten relevant veterinary medicinal products most commonly prescribed during a recent period, have been enforced since 2005 via the RCVS Guide to Professional Conduct and will remain in place.
An international group of scientists has published new results that herald a breakthrough in finding a vaccine against the most commonly diagnosed infectious disease of horses, strangles.
UK experts from the Animal Health Trust collaborated with scientists from the Swedish University of Agricultural Sciences (SLU), the Karonlinska Institutet Medical University and Intervacc AB, on the project - the results of which could benefit humans as well as animals.
Professor Andrew Waller, Head of Bacteriology at the AHT, said: "We have been working towards developing a vaccine for 7 years, and finally it seems as if all the hard work is paying off. We've already developed better ways of diagnosing exposure to the infection, and now, with the success of creating a safe and effective vaccine, it looks as if we're finally bringing together the tools necessary to eradicate this terrible disease."
The vaccine consists of seven different Streptococcus proteins and results from early tests published in PLoS Pathogens have been incredibly positive showing a high level of protection and no side effects. It is hoped that the strangles vaccine could be commercially available in the near future.
Streptococcus equi, the bacterium that causes strangles, shares 80 per cent identity with Streptococcus pyogenes - the leading cause of bacterial pharyngitis, tonsillitis and rheumatic fever in humans, which kills thousands of people each year. Scientists hope that the knowledge gained through developing the strangles vaccine will also help in developing vaccines to combat these human conditions.
Research leader, Professor Bengt Guss of SLU, said: "This is a most exciting project, where research is generating new applications and knowledge that can be used to develop vaccines against these important bacteria. This is particularly important considering the increased number of infectious diseases caused by antibiotic-resistant bacteria."
The vaccine development work was only made possible thanks to information from the Streptococcus equi genome sequencing project funded by The Horse Trust.
The Horse Trust's Chief Executive Brigadier Paul Jepson, said: "We are absolutely delighted that by pulling apart the genome of this plague of the horse world scientists have generated a truly safe and effective strangles vaccine. That this work could also benefit other animal and human health is beyond our wildest hopes."
Full text of the research findings can be found in PLoS Pathogens online at http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000584
Horiba Medical has announced the addition of the Dr. Fritz Video-Compact-System for veterinary endoscopic applications to its range of animal healthcare products. According to the company, the system is suitable for everyday small animal practice and includes a base unit and video otoscope attachment with a range of accessories for various applications.
Both the 1/3" CCD video camera and cold light source are combined in one solid and easy to operate unit, whilst the single cable technology enables the transfer of clear, magnified endoscopic images to the monitor. The camera can also be used independent of the light source and combined with a standard microscope to display urine, haematological and cytological slides. The single cable technology is facilitated by the TWIN Lock connection which enables the cable to be connected to the endoscopes with a secure bayonet lock. Offering high mobility and flexibility during examinations, the single cable makes the examination of agitated and moving animals easier.
The Dr. Fritz Video-Compact-System includes a complete set of equipment for all otoscopic examinations. The 90° video otoscope attachment can be combined with six different examination sheaths, permitting the examination of ears, oral cavity and teeth. The combined suction and irrigation sheath enables the flushing of inflammation from the ear under visual control prior to topical treatment. Horiba says that with the working sheath, removal of foreign objects, biopsy and even dental examinations of smaller animals such as rodents is much faster, easier and more secure when following the enhanced visual display.
Optional endoscopes are also available for the Dr. Fritz Video-Compact-System, expanding the possible applications by adding rhinoscopic, bronchoscopic, cystoscopic and gynaecological functionality.
Horiba will be exhibiting the Dr. Fritz Video-Compact-System at the London Vet Show at Olympia, 22nd to 23rd October 2010, on Stand M4.
A new veterinary charity is offering veterinary surgeons, nurses and others in the profession the chance to get fit and raise money for Hounds for Heroes, SPANA and the Pet Blood Bank later this year.
The Vet Charity Challenge (VCC) is looking for teams to take part in a one-day event, involving a series of physical tasks and puzzle-solving challenges along the way, so it requires a bit of brain as well as brawn. The course will feature walking / running, cycling and kayaking and anyone can take part at whatever fitness level.
As well as raising money for the charities, organisers say it will be a fun way to build up camaraderie among your colleagues outside of the work environment and also a local PR opportunity for your practice or business to enhance your community profile.
The event is expecting to raise in excess of £30,000 for charity, but organisers stress that it will need the support of and participation by the veterinary profession to ensure it is a success.
The challenge will take place on Saturday 15th September 2012 at the Royal Agricultural College, Cirencester and all details may be found on http://www.vetcharitychallenge.co.uk/. Alternatively, ring 01727 859259 for further information. The VCC says an early commitment to take part is essential and the fine detail of training can be worked out later. The VCC will provide training guidelines and help you and your team prepare itself.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets 2 and is supported by the VPMA, Mojo Consultancy and JCA Media Group.
Recent graduate, Sophie Gumble, from Head & Head Vets in Helston, Cornwall, has won a week for two in a luxury cottage in Cornwall.
Sophie won the prize after entering a draw run by Vetlife at the Veterinary Defence Society recent graduate meetings and the SPVS Lancaster Final Year Students’ Seminar last year.
The competition is run annually to raise awareness amongst younger members of the profession about the support that Vetlife provides through its support services: Vetlife Health Support, Vetlife Helpline and Vetlife Financial Support.
The prize, which was generously donated by former Vetlife Director Nicky Paull, will be offered again at the VDS reunions in 2016.
Sophie said: "I am a 2014 Liverpool graduate from Herefordshire, who entered the competition at the VDS reunion. The weekend was very useful and a great opportunity to catch up with friends and revive crazy dance moves!
"It has been a big move down to Cornwall. The busy life of a new vet, coupled with many weekends racing up the M5 to help with the family farm, has meant I am yet to really get the chance to enjoy and explore what the county of pasties and Poldark has to offer! I am excited to now have the chance to explore new parts of this wonderful county!"
A further 1,200 practices outside Europe have also embraced the scheme, which ISFM has been running with support from Purina.
There are signs that this number is set to grow. In a survey conducted by ISFM and Onswitch at BSAVA Congress this year, more than 80% of veterinary surgeons and nurses were aware of the Cat Friendly Clinic programme and over 20% said that they were working towards accreditation.
The charity says that in addition to this growth in the number of accredited practices, there has been a more general move in the profession towards positive action for the welfare of cats in daily practice, often championed by veterinary nurses.
It is often the nurses, says the charity, who have implemented the changes required to create a less stressful environment for cats. It is the nurses too who have reported changes in the behaviour of cats within the clinic. With less stress and aggression in the clinic, cats are easier to handle and owners are much happier with the relationship between them, the cat and the clinic.
Andy Sparkes, ISFM Director said: "It is so exciting to see the changes which are happening – not only are we improving our veterinary care, but we are making the whole veterinary experience better for cats and their owners.
"Clinics also notice a difference in practice revenue, as well as having very happy clients. Clients notice the difference in their cats’ behaviour and clinics become known for being cat friendly. Previously it has been difficult to market the clinic to cat clients who need a very different message to dog clients.
"The benefits of having everyone in the practice on the same cat friendly page are many: nurses' lives are made easier by having calmer cats to deal with, vets can carry out procedures more easily because cats are less aggressive, and owners receive the same cat-friendly message about cat care no matter who they speak to within the clinic. Most importantly, the patients themselves are less stressed, less fearful and more likely to have a successful diagnosis and treatment. This leads to more satisfaction, more success in treating cats, and to much better cat welfare.'
According to the charity, veterinary practice architects and designers are also taking on the idea and most new premises are now being built with separate waiting areas for cats and separate feline hospital wards.
Matthew Rees of Technic, the hospital cage manufacturer, says he has noticed "a significant and quite dramatic increase in both the awareness and desire to achieve ISFM Gold Cat Friendly Clinic accreditation".
The company has designed a new range of ISFM gold standard cat pens. Matthew said: "The CFC scheme has also made a huge difference to us as manufacturers – with International Cat Care’s assistance and straightforward advice, we have now started to understand cats and in fact 'think feline’! Our products are without doubt far better due to this and ultimately it is the cats of the world that will benefit."
Inga Feller Devaud, from Purina said: "The Cat Friendly Clinic programme is changing veterinary practice for good. Our aim is that cats will no longer be treated as small dogs and that the veterinary experience for cats and their owners will be much less stressful, and barriers to visits will be removed, improving both preventive healthcare and speed of treatment for ill cats. Purina is delighted to be partnering with International Cat Care and ISFM at the forefront of these changes."
For more information on how to become a Cat Friendly Clinic, visit: www.catfriendlyclinic.org
Genitrix has launched a scheme to help vet practices generate revenue through increasing sales of its canine mobility product, C2Collaplex. The scheme offers a money-back guarantee if clients and practices don’t see clear benefits from using C2Collaplex on dogs with mobility problems within a month.
In order to validate the scheme, clients are asked to complete a simple mobility score sheet and return it to the practice one month from the date of their original consultation. If both vet and client agree that C2Collaplex has made no difference, the practice will refund the client and Genitrix will forward on a replacement pack of C2Collaplex.
C2Collaplex, designed to promote the continuation of normal joint function in ageing and less mobile dogs, contains a range of nutritional substances, including Glucosamine HCl, Chronodroitin Sulphate, Vitamin C and Manganese, which help to support the musculo-skeletal system.
In addition, it contains purified Type II collagen which is the major protein of the cartilage in the joints. C2Collaplex is the only veterinary product to provide this protein in a purified form. According to Genitrix, it works by helping to switch off adverse processes and keeps cartilage normal.
In a retrospective study of 100 dogs presenting to practice with mobility problems, C2Collaplex was given as the only supportive agent and over 80% of veterinary surgeons and owners perceived a benefit from its use.
Commenting on the launch of ‘C2Collaplex Money Back Guarantee Scheme,’ Rob Watkins, Marketing Director of Genitrix, said: “The C2Collaplex Money Back Guarantee Scheme offers a win/win. It gives pet owners a well-priced, next generation product, which will help their dog. For the practice, it helps to build a strong revenue stream, with the guarantee of a refund if it fails to help an individual patient.”
For further information on participating, practices should contact Genitrix on 01403 786345.
Horiba Medical has announced it is the official exclusive UK distributor of the fully automated Vet abc Plus+ veterinary haematology analyser from scil animal care company GmbH, Germany.
According to the company, the compact Vet abc Plus+ provides a complete blood count (CBC), including 4-part white blood cell (WBC) differential, from only 10 µl of EDTA whole blood, in only 60 seconds.
The Vet abc Plus+ provides pre-installed settings to analyse samples from dogs, cats, horses, rabbits, mice, rats, cattle, pigs and sheep. For dogs, cats and horses, the Vet abc Plus+ provides a 4-part WBC differential blood count, including a differentiation of the leucocytes to identify lymphocytes, monocytes, granulocytes and eosinophils. Results are available in 60 seconds on screen or can be automatically printed out and transferred to the practice information system or clinical notes. For ease-of-use, the Vet abc Plus+ also incorporates a self-contained reagent and waste system which provides a clean operation whilst being easy to replenish.
Borne from an existing manufacturing partnership, scil and HORIBA Medical already have over 6000 veterinary haematology analysers placed globally. Horiba says the new UK distribution agreement enables UK veterinary professionals to not only procure the Vet abc Plus+ analyser, but also receive expert service and support directly from the manufacturer HORIBA Medical and its team of UK specialists.
For more information, visit: www.horiba.com/uk/medical
Horiba UK is to launch Gluco Calea, a new handheld blood glucose meter developed and calibrated for monitoring sugar levels in the whole blood of cats, dogs and horses, at BSAVA Congress this year.
Horiba says the new product is highly accurate and easy-to-use for the assessment of Type 1 and Type 2 Diabetes Mellitus in animals. It is also designed to be used both in veterinary practice and at home for regular monitoring and subsequent treatment optimisation.
The Gluco Calea uses disposable test strips that can measure glucose from 0.5 µL of capillary whole blood. In addition, its memory will store 300 test results and display blood glucose averages for 7, 14 and 30 days.
Paul Lymer, Veterinary Market Specialist at Horiba said: "Using a meter calibrated for humans when measuring animal blood glucose may result in inaccurate readings and an underestimation of blood glucose. This is because animals and humans have very different blood compositions, notably the concentration of glucose in blood plasma is significantly higher in animals. Therefore, it is essential to use a blood glucose meter specifically developed for animals such as the Gluco Calea."
Horiba is also highlighting 'Gold energy plus liquid sugar', its new vanilla-flavoured gel for hypoglycemia in small animals. The company says it is easy to give, rapid acting and highly effective over a long period.
For more information and a special offer whereby you can claim a free Gluco Calea meter with every purchase of 50 test strips, visit stand 505 at the BSAVA Congress, or www.horiba.com/uk/medical/products/animal-healthcare.